Skip to main content

Jeff Lagasse

By Jeff Lagasse | 04:13 pm | July 19, 2021
Failing to follow through on price transparency requirements could alienate a large swath of a given health system's customer base.
By Jeff Lagasse | 12:24 pm | July 19, 2021
Arkansas, Florida, Missouri and Nevada are all experiencing big surges, due principally to the Delta variant and low vaccination numbers.
By Jeff Lagasse | 11:21 am | July 19, 2021
CMS will release traditional and digital advertisements and educational materials directed to those with high uninsured rates.
By Jeff Lagasse | 12:30 pm | July 16, 2021
Clover is discontinuing its current co-branding arrangement with Walmart to offer MA plans in Georgia.
By Jeff Lagasse | 05:14 pm | July 15, 2021
While revenues are down year-over-year, they still surpassed Wall Street’s expectations.
By Jeff Lagasse | 12:36 pm | July 15, 2021
Since February 15, 1.5 million Americans have signed up on HealthCare.gov, with 600,000 more enrolling through state-based marketplaces.
By Jeff Lagasse | 04:21 pm | July 14, 2021
The union specifically mentioned the Delta variant of the coronavirus, against which vaccines may be less effective.
By Jeff Lagasse | 01:12 pm | July 14, 2021
Medicaid will see increased costs through beneficiaries’ direct payment of the drug, plus potentially higher Medicare premium payments.
By Jeff Lagasse | 06:25 pm | July 13, 2021
People are starting to seek new avenues of care, using 2020 as an opportunity to work on health goals and reexamine priorities.
By Jeff Lagasse | 02:15 pm | July 13, 2021
The analysis will target aducanumab, recently approved by the FDA, as well as any future monoclonal antibodies that treat Alzheimer’s.